Clinical Trial Update: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of Umbilical Cord Blood T-Regulatory Cell infusion followed by donor cord blood transplant in patients with high-risk leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myelofibrosis
• Plasma Cell Neoplasm

Drugs mentioned

• Umbilical Cord Blood T-Regulatory Cell Infusion

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Graft Versus Host Disease, Leukemia | Phase 1 | Status: TERMINATED